AutoArmy’s life sciences AI consulting connects pharma, biotech, and medical device leaders with vetted experts, mapping a vendor-neutral path to faster discovery, cleaner trials, and compliant AI across the product lifecycle.
AI Readiness Assessment
Running
74
/ 100
Readiness index
6 workflows ranked by data-readiness × revenue impact.
+6 since last scan
Data readiness
72
ROI confidence
88
Risk coverage
64
Recommendation · 1.4s
Start with the claims-triage agent, est. 4.2× ROI in year one.
4.2×
Projected ROI · Year one
The science is hard and the rules are strict. McKinsey estimates gen AI could create $60 billion to $110 billion a year for pharma and medical products. These six gaps slow life sciences AI consulting most, each with the evidence behind it.
01
Discovery takes years and billions. Rivals using AI screen targets in weeks, not months, compounding their lead. Slow, manual research cedes the best molecules to faster rivals. Speed is the whole game in discovery.
Every engagement stays advisory. We assess your goals, scope what fits a regulated setting, and guide the work safely. You own each decision, and FDA-aware governance is built in from the start.
01
Map where AI moves the needle across R&D, trials, and commercial. Advisory work scores use cases by value, feasibility, and regulatory risk. It then sequences a roadmap tied to ROI. The plan targets speed to market.
Advisory framework
Fewer wrong turns · one signed route
Get an independent read on your highest-value, FDA-aware AI opportunities, plus a roadmap your team can act on. No long commitment, just a clear next step.
Ready to lead with AI innovation?
Book a free consultationThese use cases deliver measurable value across the lifecycle. Each pairs a real workflow with the result it produces.
Foundation models screen molecular targets in weeks, not months. Research teams then pursue the best candidates faster. Less effort goes to dead ends. The pipeline fills with stronger candidates. Bets get smarter, and budgets stretch further.
01
02
AI designs trial protocols and selects cohorts from real-world data. Studies enroll the right patients faster. Costly amendments and delays drop. Trials reach readouts sooner. Time saved is money saved, and patients wait less for new therapies.
Models check submission packages against regulatory expectations and flag validation gaps early. Regulatory teams then file with fewer rejections. Rework drops sharply. Reviews go more smoothly. Approvals come faster, and products reach market sooner.
03
04
AI scans real-world and postmarket data for safety signals. Adverse events surface earlier. Teams act fast, and patients stay protected after launch.
Gen AI drafts study reports and regulatory documents from source data. Medical writers move faster. Humans still review every claim before it goes out.
05
06
AI inspects output and forecasts demand across the supply chain. Manufacturing holds quality and avoids the shortages that delay therapies and erode trust.
Our model is simple. Independent advice comes first, and a connection to the right delivery team follows. You get strategy and execution without the usual handoff gap.
Advisory comes first, then we connect you with vetted partners who know the science. You gain senior strategy plus a delivery team proven in regulated life sciences settings.
Partners are matched to pharma, biotech, or medical device, not a generic bucket. That fit means the team already knows your regulators, data, and product lifecycle. Less ramp-up, more progress.
Partners bring real experience with FDA validation and SaMD rules. Your AI is built to pass review. A rejection that costs months is the risk we help you avoid.
Skip the long RFP cycle. Because the network is vetted in advance, the right team starts in days, so your pipeline keeps moving instead of waiting on procurement.
Every partner meets the privacy and security bar life sciences demands. Controls map to HIPAA, GDPR, and SOC 2, so patient and trial data stay protected.
No generalist overhead or junior ramp-up. You work with people who know the science and the rules. The engagement moves fast, and the advice lands right.
Advisory framework
Fewer wrong turns · one signed route
Tell us your pipeline and your goals. We will map the path and match you with a vetted, regulated-ready team. The first step is a short assessment.
Ready to lead with AI innovation?
Book a free consultationStraight answers to the questions pharma and biotech leaders ask most.
What is life sciences AI consulting and what does it cover?
It is advisory help that applies AI across the life sciences lifecycle: discovery, clinical trials, regulatory, safety, and manufacturing. Advisors assess your goals and compliance needs, prioritize use cases, and match you with a delivery team that knows the science. The aim is measurable value, like faster discovery and cleaner submissions, all under FDA-aware governance, not an experiment that stalls.
How is AI being used in pharma and biotech today?
Widely, and growing fast. Teams use machine learning to identify drug targets, design trials, select patient cohorts, draft regulatory documents, and detect safety signals in real-world data. Generative AI now speeds medical writing and discovery. McKinsey estimates gen AI could add $60 billion to $110 billion a year to pharma and medical products, much of it from R&D and operations productivity.
What should a CTO look for in a life sciences AI consulting partner?
Domain depth first: real experience with FDA validation, SaMD rules, and trial data, not generic AI skills. Look for proof in your sub-vertical, strong data privacy and security, and a track record of getting models through review. Favor advisors who stay vendor-neutral, so the recommendation fits your science and pipeline rather than a single platform.
How does AutoArmy match us with the right life sciences AI consulting partner?
We begin with an advisory assessment of your goals, data, and compliance needs. From there we match you with vetted partners whose record fits your sub-vertical and regulators. Because we stay vendor-neutral, the recommendation follows your needs, not a quota. You keep one accountable advisor, gain a proven team, and approve the partner before any work begins.
How long does it take to start a life sciences AI consulting engagement?
Faster than a traditional RFP. A focused assessment can begin within days, since the partner network is vetted in advance. An initial use case, like documentation AI or a discovery pilot, can show value in weeks. Advisors sequence the work so early wins are proven, and compliance is validated before scaling.
What regulations do life sciences AI consulting partners need to understand?
At minimum, FDA expectations for AI used in drug submissions and Software as a Medical Device, plus HIPAA for protected health information and GDPR for global trials. Strong partners also map to the NIST AI RMF and SOC 2 for security. Advisors confirm a partner’s regulatory experience before any introduction, so your AI is built to pass review.
Businesses see real AI returns by making fewer wrong decisions early. AutoArmy’s advisory process helps businesses make the right call before the budget is set.
30 minutes · no cost · no sales deck
"Three weeks from intake to a working agent in your stack."
From the AutoArmy advisory brief · 2026
30 minutes, no cost, no sales deck. Tell us a little about your goals and a preferred time, and a senior AI consultant will confirm.
